Related references
Note: Only part of the references are listed.Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China
Jin-jin Zhang et al.
ALLERGY (2020)
Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS
Yushun Wan et al.
JOURNAL OF VIROLOGY (2020)
COVID-19 and Avoiding Ibuprofen. How Good Is the Evidence?
Gurusaravanan Kutti Sridharan et al.
AMERICAN JOURNAL OF THERAPEUTICS (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Safety of Ibuprofen in Patients With COVID-19 Causal or Confounded?
Mohit Sodhi et al.
CHEST (2020)
A Comparative Study on the Clinical Features of Coronavirus 2019 (COVID-19) Pneumonia With Other Pneumonias
Dahai Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
Gianluca Trifiro et al.
DRUG SAFETY (2020)
Chloroquine for COVID-19 Infection
Nicholas Moore
DRUG SAFETY (2020)
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Clinical features and treatment of COVID-19 patients in northeast Chongqing
Suxin Wan et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Covid-19: European drugs agency to review safety of ibuprofen
Michael Day
BMJ-BRITISH MEDICAL JOURNAL (2020)
Covid-19: ibuprofen can be used for symptoms, says UK agency, but reasons for change in advice are unclear
Ingrid Torjesen
BMJ-BRITISH MEDICAL JOURNAL (2020)
Covid-19: ibuprofen should not be used for managing symptoms, say doctors and scientists
Michael Day
BMJ-BRITISH MEDICAL JOURNAL (2020)
Non-steroidal anti-inflammatory drugs and covid-19
Paul Little
BMJ-BRITISH MEDICAL JOURNAL (2020)
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
Lei Fang et al.
LANCET RESPIRATORY MEDICINE (2020)
COVID-19 pandemic and therapy with ibuprofen or renin-angiotensin system blockers: no need for interruptions or changes in ongoing chronic treatments
Oliver Zolk et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom
Sheng-Chia Chung et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Inhibitors of the Renin-Angiotensin-Aldosterone System and Covid-19
John A. Jarcho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
Giuseppe Mancia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19
Harmony R. Reynolds et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19
Muthiah Vaduganathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Considerations for pharmacoepidemiological analyses in the SARS-CoV-2 pandemic
Anton Pottegard et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)
Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom
Sarah Gabriel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients
Guillaume Voiriot et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System
Nicholas Moore et al.
DRUG SAFETY (2019)
Nonsteroidal Antiinflammatory Drug Use and Clinical Outcomes of Community-acquired Pneumonia
Damien Basille et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study
Sinem Ezgi Gulmez et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
Usage patterns of paracetamol in France
Mai Duong et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Liver transplant associated with paracetamol overdose: results from the seven-country SALT study
Sinem Ezgi Gulmez et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Ibuprofen Attenuates Cardiac Fibrosis in Streptozotocin-Induced Diabetic Rats
Weili Qiao et al.
CARDIOLOGY (2015)
Usage patterns of 'over-the-counter' vs. prescription-strength nonsteroidal anti-inflammatory drugs in France
Mai Duong et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Transplantation for Acute Liver Failure in Patients Exposed to NSAIDs or Paracetamol (Acetaminophen) The Multinational Case-Population SALT Study
Sinem Ezgi Gulmez et al.
DRUG SAFETY (2013)
Ibuprofen, paracetamol, and steam for patients with respiratory tract infections in primary care: pragmatic randomised factorial trial
Paul Little et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Impact of safety alerts on measures of disproportionality in spontaneous reporting databases - The notoriety bias
Antoine Pariente et al.
DRUG SAFETY (2007)
Invasive group A streptococcal infection and nonsteroidal antiinflammatory drug use among children with primary varicella
SM Lesko et al.
PEDIATRICS (2001)
Share Paper
